Celebrating Women Leaders

March offers an opportunity to reflect on the contributions of women across medicine—and within dermatology, those contributions continue to shape the specialty in measurable ways. In recognition of Women’s History Month, this Dermatology Times issue features a timely cover feature by Nicole A. Negbenebor, MD, FAAD, examining the evolving role of women leaders in Mohs micrographic surgery for nonmelanoma skin cancer. As procedural volumes rise and practice models shift, Negbenebor offers a perspective that shows how mentorship, representation, and structural support are influencing the next generation of surgeons in this highly specialized field.

Beyond the cover feature, this issue explores several areas where clinical considerations and patient demographics intersect with emerging evidence. For acne, Lisa Swanson, MD, evaluates how formulation science, barrier biology, and social media trends are reshaping pediatric and adolescent dermatology. Nagasai C. Adusumilli, MD, MBA; Leonardo Tjahjono, MD; and Adam J. Friedman, MD, examine the off-label use of lebrikizumab (Eli Lilly and Company) for Hailey-Hailey disease, highlighting mechanistic rationale and early clinical experience in a condition with limited durable options. We also turn our attention to perimenopause, with Amanda Caldwell, MSN, APRN-C, addressing the cutaneous manifestations of hormonal transition and practical strategies for counseling and management in midlife patients.

With the American Academy of Dermatology Annual Meeting taking place this month in Denver, Colorado, we encourage clinicians who attend or present data to email [email protected] to share their key takeaways from the meeting.

As always, Dermatology Times delivers the most up-to-date clinical content, featuring innovative studies, FDA approvals, exclusive interviews, and expert perspectives. Stay informed with the latest data—subscribe to Dermatology Times’ e-newsletters and follow us on Facebook, LinkedIn, and X.

Mike Hennessy Jr
Chairman and CEO
MJH Life Sciences